Scholarly Index
Andrew L. Feldman
Mayo Clinic; 19,559 total citations; 426 total publications; best world rank #46
Mayo Clinic
19,559Total citations
426Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lymphoma Diagnosis and Treatment | Lifetime | 259 | US 130 | 99.22 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 90 | US 47 | 98.78 |
| Viral-associated cancers and disorders | Lifetime | 223 | US 110 | 98.63 |
| T-cell and Retrovirus Studies | Lifetime | 200 | US 101 | 97.77 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 766 | US 355 | 98.12 |
| Angiogenesis and VEGF in Cancer | Lifetime | 612 | US 273 | 96.52 |
| Histiocytic Disorders and Treatments | Lifetime | 126 | US 72 | 96.75 |
| Tumors and Oncological Cases | Lifetime | 366 | US 215 | 96.78 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 876 | US 353 | 90.91 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 141 | US 71 | 98.52 |
| Viral-associated cancers and disorders | 2021-2025 | 111 | US 64 | 95.16 |
| T-cell and Retrovirus Studies | 2021-2025 | 46 | US 14 | 94.29 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 113 | US 43 | 94.58 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 678 | US 288 | 93.51 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 764 | US 256 | 71.39 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 975 | US 338 | 65.85 |